1. Home
  2. BSII vs SCPH Comparison

BSII vs SCPH Comparison

Compare BSII & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSII
  • SCPH
  • Stock Information
  • Founded
  • BSII 2024
  • SCPH 2013
  • Country
  • BSII Hong Kong
  • SCPH United States
  • Employees
  • BSII N/A
  • SCPH N/A
  • Industry
  • BSII
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BSII
  • SCPH Health Care
  • Exchange
  • BSII Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • BSII 189.9M
  • SCPH 160.6M
  • IPO Year
  • BSII 2024
  • SCPH 2017
  • Fundamental
  • Price
  • BSII $10.01
  • SCPH $3.28
  • Analyst Decision
  • BSII
  • SCPH Strong Buy
  • Analyst Count
  • BSII 0
  • SCPH 2
  • Target Price
  • BSII N/A
  • SCPH $15.00
  • AVG Volume (30 Days)
  • BSII 4.2K
  • SCPH 251.3K
  • Earning Date
  • BSII 01-01-0001
  • SCPH 03-12-2025
  • Dividend Yield
  • BSII N/A
  • SCPH N/A
  • EPS Growth
  • BSII N/A
  • SCPH N/A
  • EPS
  • BSII N/A
  • SCPH N/A
  • Revenue
  • BSII N/A
  • SCPH $30,278,000.00
  • Revenue This Year
  • BSII N/A
  • SCPH $173.14
  • Revenue Next Year
  • BSII N/A
  • SCPH $131.01
  • P/E Ratio
  • BSII N/A
  • SCPH N/A
  • Revenue Growth
  • BSII N/A
  • SCPH 303.87
  • 52 Week Low
  • BSII $9.86
  • SCPH $3.08
  • 52 Week High
  • BSII $10.30
  • SCPH $6.54
  • Technical
  • Relative Strength Index (RSI)
  • BSII N/A
  • SCPH 41.79
  • Support Level
  • BSII N/A
  • SCPH $3.15
  • Resistance Level
  • BSII N/A
  • SCPH $3.52
  • Average True Range (ATR)
  • BSII 0.00
  • SCPH 0.18
  • MACD
  • BSII 0.00
  • SCPH -0.00
  • Stochastic Oscillator
  • BSII 0.00
  • SCPH 15.22

About BSII Black Spade Acquisition II Co Class A Ordinary Share

Black Spade Acquisition II Co is a blank check company.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Share on Social Networks: